Dastranj Mahsa, Farahani Abbas, Hashemi Shahraki Abdolrazagh, Atashi Sara, Mohajeri Parviz
Microbiology Department, Kurdistan Science and Research Branch, Islamic Azad University, Sanandaj, Iran.
Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Clin Respir J. 2018 Mar;12(3):996-1002. doi: 10.1111/crj.12617. Epub 2017 Mar 9.
Infections by non-tuberculous mycobacteria (NTM) has rapidly increased in recent years, due to high infection rates related to the populations at risk like immunocompromised individuals, patients predisposed by prior pulmonary. The aim of this study was to investigate the presence of NTM in clinical samples and genetic diversity using 16S rRNA and rpoB sequence analysis.
A cross-sectional study was conducted on 45 diverse isolates collected from sputum in 2 years 2014-2015 using standard decontamination procedure. All mycobacterial isolates were grown on LJ medium and also conventional tests for preliminary identification of mycobacteria rely on traits and then DNA extraction. PCR was performed, and sequencing of 16S rRNA and rpoB genes was applied for NTM strains identification.
A total of 45 isolates collected, 37 samples (83%) were evaluated as NTM. All NTM strains using molecular methods by sequencing 16S rRNA and rpoB gene were identified, by this way 12 different species have been identified which sequencing of rpoB was able to identify all species. The major species obtained were Mycobacterium simiae (22%), M. fortuitum (19%), and M. abscessus (13%).
The results of our study showed that the patients were infected by a wide range of atypical mycobacteria. It was concluded that 16S rRNA gene sequencing coupled with rpoB marker is a high discriminatory power in identification of NTM. The presence of various species in clinical samples in Iran emphasizes the use of molecular method like sequence analysis of genes is necessary for reliable identification.
近年来,非结核分枝杆菌(NTM)感染迅速增加,这是由于免疫功能低下个体、既往有肺部疾病易患患者等高危人群的感染率较高。本研究的目的是通过16S rRNA和rpoB序列分析,调查临床样本中NTM的存在情况及其遗传多样性。
2014 - 2015年期间,采用标准净化程序,对从痰液中收集的45株不同分离株进行横断面研究。所有分枝杆菌分离株均在罗氏培养基上生长,并且分枝杆菌的初步鉴定常规检测依赖于特征,然后进行DNA提取。进行PCR,并将16S rRNA和rpoB基因测序应用于NTM菌株鉴定。
共收集到45株分离株,其中37份样本(83%)被评估为NTM。通过对16S rRNA和rpoB基因进行测序的分子方法鉴定了所有NTM菌株,通过这种方式鉴定出12个不同的物种,其中rpoB测序能够鉴定所有物种。主要的物种有猿分枝杆菌(22%)、偶然分枝杆菌(19%)和脓肿分枝杆菌(13%)。
我们的研究结果表明,患者感染了多种非典型分枝杆菌。得出的结论是,16S rRNA基因测序结合rpoB标记在NTM鉴定中具有很高的鉴别力。伊朗临床样本中存在多种物种,这强调了使用基因序列分析等分子方法进行可靠鉴定的必要性。